TLR9-IN-3 is a TLR9 antagonist with an IC 50 of 0.4 μM. TLR9-IN-3 shows selectivity for TLR4 and TLR8 , and inhibits CD69 activation in human whole blood with a corresponding IC 50 of 1.1 μM. TLR9-IN-3 can be used in research related to pulmonary fibrosis.
Products | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Lung Fibrosis | Products > Research Areas > Inflammation/Immunology
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.